Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Morgan Stanley raised Lemonade Inc (NYSE:LMND) price target from $80 to $85. Morgan Stanley analyst Bob Huang upgraded the stock from Equal-Weight to Overweight. Lemonade shares closed at $57.74 on Monday. See how other analysts view this stock.
- Mizuho cut the price target for Canadian Solar Inc (NASDAQ:CSIQ) from $21 to $19. Mizuho analyst Maheep Mandloi upgraded the stock from Underperform to Neutral. Canadian Solar shares closed at $18.04 on Monday. See how other analysts view this stock.
- Piper Sandler raised Tandem Diabetes Care Inc (NASDAQ:TNDM) price target from $21 to $33. Piper Sandler analyst Matt O’Brien upgraded the stock from Neutral to Overweight. Tandem Diabetes Care shares closed at $21.91 on Monday. See how other analysts view this stock.
- Stifel increased price target for Ichor Holdings Ltd (NASDAQ:ICHR) from $30 to $55. Stifel analyst Brian Chin upgraded the stock from Hold to Buy. Ichor shares closed at $42.59 on Monday. See how other analysts view this stock.
- Needham raised the price target for Semtech Corp (NASDAQ:SMTC) from $100 to $105. Needham analyst N. Quinn Bolton maintained a Buy rating. Semtech shares closed at $89.00 on Monday. See how other analysts view this stock.
- HC Wainwright & Co. cut Eupraxia Pharmaceuticals Inc (NASDAQ:EPRX) price target from $12 to $11. HC Wainwright & Co. analyst Brandon Folkes maintained a Buy rating. Eupraxia Pharmaceuticals shares closed at $7.39 on Monday. See how other analysts view this stock.
- Evercore ISI Group raised National Storage Affiliates Trust (NYSE:NSA) price target from $33 to $41. Evercore ISI Group analyst Steve Sakwa upgraded the stock from Underperform to In-Line. National Storage Affiliates Trust shares closed at $40.23 on Monday. See how other analysts view this stock.
- Needham raised Stoke Therapeutics Inc (NASDAQ:STOK) price target from $35 to $40. Needham analyst Joseph Stringer maintained a Buy rating. Stoke Therapeutics shares closed at $33.96 on Monday. See how other analysts view this stock.
- Morgan Stanley increased the price target for Adecoagro SA (NYSE:AGRO) from $9.5 to $13. Morgan Stanley analyst Javier Martinez upgraded the stock from Underweight to Equal-Weight. Adecoagro shares closed at $10.90 on Monday. See how other analysts view this stock.
- Morgan Stanley slashed Dollar Tree Inc (NASDAQ:DLTR) price target from $146 to $126. Morgan Stanley analyst Simeon Gutman maintained an Equal-Weight rating. Dollar Tree shares closed at $114.36 on Monday. See how other analysts view this stock.
Considering buying SMTC stock? Here’s what analysts think:

Photo via Shutterstock
Login to comment